Nosocomial dissemination of plasmids carrying blaTEM-24, blaDHA-1, aac(6')-Ib-cr, and qnrA6 in Providencia spp. strains isolated from a Tunisian hospital

Diagnostic Microbiology and Infectious Disease

Volumn 81, Issue 1, 2015, Pages 50-52

  Mahrouki, Sihem ^a   Chihi, Hela ^a   Bourouis, Amel ^a   Ayari, Khaoula ^a   Ferjani, Mustapha ^b   Moussa, Mohamed Ben ^b   Belhadj, Omrane ^a  

^a FACULTÉ DES SCIENCES DE TUNIS   (Tunisia)

^b MILITARY HOSPITAL OF TUNIS   (Tunisia)

Author keywords

AmpC lactamase; ESBL; IncA C plasmid; Providencia; QnrA6

Indexed keywords

BETA LACTAMASE AMPC; CEFOXITIN; CEFTAZIDIME; CHLORAMPHENICOL; IMIPENEM; OFLOXACIN; QUINOLONE DERIVATIVE; SULFONAMIDE; AMPC BETA-LACTAMASES; BACTERIAL PROTEIN; BETA LACTAMASE; BETA-LACTAMASE TEM-2;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; BLADHA 1 GENE; BLATEM 24 GENE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ESCHERICHIA COLI; FEMALE; GENE AMPLIFICATION; GENE LOCATION; GENE MUTATION; GYRA GENE; GYRB GENE; HOSPITAL INFECTION; HUMAN; MALE; MIDDLE AGED; MOLECULAR SIZE; NONHUMAN; PARC GENE; PARE GENE; PROVIDENCIA RETTGERI; PROVIDENCIA STUARTII; QNRA6 GENE; TUNISIAN; CROSS INFECTION; DRUG EFFECTS; ENTEROBACTERIACEAE INFECTIONS; GENETICS; HOSPITAL; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; PATHOGENICITY; PLASMID; PROVIDENCIA; TREATMENT OUTCOME; TUNISIA;

BACTERIAL PROTEINS; BETA-LACTAMASES; CROSS INFECTION; ENTEROBACTERIACEAE INFECTIONS; GENES, BACTERIAL; HOSPITALS; HUMANS; MICROBIAL SENSITIVITY TESTS; PLASMIDS; PROVIDENCIA; TREATMENT OUTCOME; TUNISIA;

EID: 84916226373     PISSN: 07328893     EISSN: 18790070     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2014.09.021     Document Type: Article

References (19)

1. CMY-16 and qnrA6 Genes and Its Transfer through Three Clones of Providencia stuartii during a Two-Year Outbreak in a Tunisian Burn Unit. Antimicrob Agents Chemother 2012, 56:1342-1349.
2. Bourouis A., Dubois V., Chihi H., Belhadj C., Ben Moussa M., Quentin C., et al. Detection of plasmid-mediated quinolone resistance determinant QnrS1 in an extended-spectrum β-lactamase producing Enterobacter cloacae in Tunisia. Ann Microbiol 2010, 60:423-427.
3. Carattoli A., Bertini A., Villa L., Falbo V., Hopkins K.L., Threlfall E.J. Identification of plasmids by PCR-based replicon typing. J Microbiol Methods 2005, 63:219-228.
4. Cattoir V., Poirel L., Rotimi V., Soussy C.J., Nordmann P. Multiplex PCR for detection of plasmid-mediated quinolone resistance qnr genes in ESBL-producing enterobacterial isolates. J Antimicrob Chemother 2007, 60:394-397.
5. Chouchani C., El Salabi A., Marrakchi R., Ferchichi L., Wash T.R. Characterization of IncA/C conjugative plasmid harbouring blaTEM-52 and blaCTX-M-15 extended-spectrum β-lactamases in clinical isolates of Escherichia coli in Tunisia. Eur J Clin Microbiol Infect Dis 2012, 31:1081-1087.
6. Clinical and Laboratory Standards Institute (CLSI) Performance Standards for Antimicrobial Susceptibility Testing; Twentieth Informational Supplement. CLSI document M100-S20 2010, Clinical and Laboratory Standards Institute, Wayne, PA.
7. CTX-M-15 associated with ISEcp1 in Proteus mirabilis and Morganella morganii isolated at Military Hospital of Tunis, Tunisia. J Med Microbiol 2012, 61:1286-1289.
8. Mahrouki S., Bourouis A., Chihi H., Ouertani R., Ferjani M., Ben Moussa M., et al. First characterisation of plasmid-mediated quinolone resistance-qnrS1 co-expressed blaCTX-M-15 and blaDHA-1 genes in clinical strain of Morganella morganii recovered from a Tunisian intensive care unit. Indian J Med Microbiol 2012, 30:437-441.
9. Mahrouki S., Perilli M., Bourouis A., Chihi H., Ferjani M., Ben Moussa M., et al. Prevalence of quinolone resistance determinant qnrA6 among broad and extended-spectrum-β-lactams-resistant-Proteus mirabilis and Morganella morganii clinical isolates with sul1-type class 1 integrons association in a Tunisian hospital. Scand J Infect Dis 2013, 45(8):600-605.
10. Mammeri H., Van De Loo M., Poirel L., Martinez-Martinez L., Nordmann P. Emergence of plasmid-mediated quinolone resistance in Escherichia coli in Europe. Antimicrob Agents Chemother 2005, 49:71-76.
11. MarcadeD G., Deschamps C., Boyd A., Gautier V., Picard B., Branger C., et al. Replicon typing of plasmids in Escherichia coli producing extended-spectrum β-lactamases. J Antimicrob Chemother 2009, 63:67-71.
12. Marchandin H., Carriere C., Sirot D., Jean-Pierre H., Darbas H. TEM-24 produced by four different species of Enterobacteriaceae, including Providencia rettgeri, in a single patient. Antimicrob Agents Chemother 1999, 43:2069-2073.
13. Mnif B., Ktari S., Chaari A., Medhioub F., Rhimi F., Bouaziz M. Nosocomial dissemination of Providencia stuartii isolates carrying blaOXA-48, blaPER-1, blaCMY-4 and qnrA6 in a Tunisian hospital. J Antimicrob Chemother 2012, 26:1-4.
14. Pérez-Pérez F.J., Hanson N.D. Detection of plasmid-mediated AmpC beta-lactamases genes in clinical isolates by using multiplex PCR. J Clin Microbiol 2002, 40(6):2153-2162.
15. Perilli M., Forcella C., Celenza G., Frascaria P., Sergatore B., Pellegrini C., et al. Evidence for qnr B1 and aac(6')-Ib-cr in CTX-M-15-producing uropathogenic Enterobacteriaceae in an Italian teaching hospital. Diagn Microbiol Infect Dis 2009, 64:90-93.
16. Poirel L., Bonnin R.A., Nordmann P. Genetic support and diversity of acquired extended-spectrum b-lactamases in Gram-negative rods. Infect Genet Evol 2012, 12(5):883-893.
17. Robin F., Delmas J., Brebion A., Dubois D., Constantin J.M., Bonnet R. TEM-158 (CMT-9), a new member of the CMT-type extended-spectrum b-lactamases. Antimicrob Agents Chemother 2007, 51:4181-4183.
18. Shahid M., Sobia F., Singh A., Malik A., Khan H.M., Jonas D., et al. Beta-lactams and beta-lactamase-inhibitors in current- or potential-clinical practice: a comprehensive update. Crit Rev Microbiol 2009, 35:81-108.
19. Tumbarello M., Citton R., Spanu T., Sanguinetti M., Romano L., Fadda G., et al. ESBL-producing multidrug-resistant Providencia stuartii infections in a university hospital. J Antimicrob Chemother 2004, 53(2):277-282.